Nicholas Piramal India Ltd and AstraZeneca AB, Sweden have signed a development and know-how agreement.
Under this agreement, the companies will establish a framework for future collaboration for development of processes for the manufacture of intermediates active ingredients or bulk drugs for supply to AstraZeneca.
The development and know-how agreement does not have a fixed tenure. It is envisaged to continue and last so long as the Parties have products under-development, Nicholas Piramal said here.
If the collaboration on any of the products development is successful, the agreement provides for the parties to further negotiate terms of an agreement for supply of the product by the company to AstraZeneca.